QualityStocks would like to highlight
Sohm, Inc. (
PINK: SHMN), a globally recognized pharmaceutical manufacturer that develops, manufactures, and distributes generic, private label, and Sohm-innovated pharmaceutical, cosmeceutical, and nutraceutical products. The company exports product worldwide, with a focus on distribution in emerging markets such as Africa, Latin America, and Southeast Asia.
In the company’s news,
Sohm is committed to being a global leader in improving the health and quality of people’s lives. Their focus is on the development, manufacturing and sale of quality branded generic pharmaceuticals as well as the company’s own innovative line of cosmeceuticals and nutraceuticals. As Sohm says, they add life to lives.
Generic pharmaceuticals have gained wide acceptance with the public, physicians, and pharmacists. Cost savings can be substantial using generic drug substitutes while the quality remains the same. As more and more drugs lose patent protection over the coming years, global expansion of the generic pharmaceuticals market is a given.
Sohm was voted the fastest growing generics prescription drug manufacturer in 2012 at the 30th All India Conference of the National Integrated Medical Association. The Company has its U.S. headquarters in Buena Park, CA, with international headquarters located in India. The company also has several corporate offices located within the UK and China. This global reach requires a commitment by Sohm to strictly adhere to all applicable international regulatory requirements and to the highest degree of industry standards. Sohm ensures compliance by continuous assessment and monitoring of the output of the existing quality systems, and the application of evolving industry guidelines and regulations including all WHO-CGMP and USFDA guidelines.
In addition to producing and selling high quality generic pharmaceuticals, Sohm private brands various supplements and has developed expertise in various drug delivery technologies. The company has gained recognition for their multiple drug delivery technologies which include solid dosage form, oral-controlled and sustained release semi-solid, liquid, oral Trans’ mucosal, transdermal, gel, injectable, plus the application of these technologies to proprietary drug forms. These and other innovations have propelled Sohm to prominence in generic pharmaceutical delivery systems.
With unabated increases in healthcare costs, an aging population, and multiple branded products losing patent protection over the coming years, SOHM is well positioned to make an impact the global generic pharmaceuticals market.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
